A phase 1 study of the safety, tolerability, pharmacodynamics, and pharmacokinetics of tenapanor in healthy Japanese volunteers
Crossref DOI link: https://doi.org/10.1007/s10157-016-1302-8
Published Online: 2016-07-01
Published Print: 2017-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Johansson, Susanne
Rosenbaum, David P.
Knutsson, Mikael
Leonsson-Zachrisson, Maria
Funding for this research was provided by:
AstraZeneca
License valid from 2016-07-01